Enisa Gutic
Ottakring, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna.
Journal: Journal of virus eradication
Published: July 18, 2025
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers.
Journal: Journal of virus eradication
Published: March 01, 2023
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
Journal: Journal of virus eradication
Published: September 20, 2022
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.
Journal: PloS one
Published: October 08, 2019
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Journal: European journal of gastroenterology & hepatology
Published: November 10, 2017
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals.
Journal: Journal of viral hepatitis
Published: August 30, 2017
Early decrease of liver stiffness after initiation of antiviral therapy in patients with chronic hepatitis C.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 27, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026